Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate whether inhibition of serum prolactin levels below
normal range during cabergoline administration may reduce the recurrence rate after drug
withdrawal in patients with prolactinomas.